Further Weakness as Hainan Haiyao (SZSE:000566) Drops 6.7% This Week, Taking Five-year Losses to 26%
Further Weakness as Hainan Haiyao (SZSE:000566) Drops 6.7% This Week, Taking Five-year Losses to 26%
In order to justify the effort of selecting individual stocks, it's worth striving to beat the returns from a market index fund. But even the best stock picker will only win with some selections. At this point some shareholders may be questioning their investment in Hainan Haiyao Co., Ltd. (SZSE:000566), since the last five years saw the share price fall 26%. Even worse, it's down 21% in about a month, which isn't fun at all. We do note, however, that the broader market is down 9.1% in that period, and this may have weighed on the share price.
为了证明选择个别股票的努力是合理的,值得努力超越市场指数基金的回报。但即使是最好的股票选择者,也只会在某些选择中获胜。在这一点上,一些股东可能正在质疑他们对海南海药股份有限公司(SZSE:000566)的投资,因为过去五年股价下跌了26%。更糟糕的是,约一个月内股价下跌了21%,这一点可不令人愉快。然而,我们注意到,在此期间,整体市场下跌了9.1%,这可能对股价造成了一定压力。
After losing 6.7% this past week, it's worth investigating the company's fundamentals to see what we can infer from past performance.
在过去一周下跌了6.7%之后,值得调查公司的基本面,以便从过去的表现中推断出我们能得到什么。
Given that Hainan Haiyao didn't make a profit in the last twelve months, we'll focus on revenue growth to form a quick view of its business development. Generally speaking, companies without profits are expected to grow revenue every year, and at a good clip. That's because fast revenue growth can be easily extrapolated to forecast profits, often of considerable size.
鉴于海南海药在过去十二个月没有盈利,我们将关注营业收入的增长,以快速了解其业务发展。一般而言,没有利润的公司预计每年都要增长营业收入,并且增长幅度较大。这是因为快速的营业收入增长可以轻松推断出利润预期,通常相当可观。
In the last five years Hainan Haiyao saw its revenue shrink by 13% per year. That's definitely a weaker result than most pre-profit companies report. It seems pretty reasonable to us that the share price dipped 5% per year in that time. This loss means the stock shareholders are probably pretty annoyed. It is possible for businesses to bounce back but as Buffett says, 'turnarounds seldom turn'.
在过去五年中,海南海药的营业收入每年缩减13%。这个结果明显弱于大多数未盈利公司的报告。我们认为,在那段时间,股价每年下降5%是相当合理的。这种损失意味着股票股东可能相当恼火。企业确实有可能复苏,但正如巴菲特所说,‘翻身的事情很少发生’。
You can see below how earnings and revenue have changed over time (discover the exact values by clicking on the image).
您可以在下面看到盈利和营业收入随时间的变化(通过点击图片发现确切值)。
Take a more thorough look at Hainan Haiyao's financial health with this free report on its balance sheet.
通过这份关于海南海药资产负债表的免费报告,更全面地了解海南海药的财务健康状况。
A Different Perspective
不同的视角
Hainan Haiyao provided a TSR of 3.6% over the last twelve months. Unfortunately this falls short of the market return. But at least that's still a gain! Over five years the TSR has been a reduction of 5% per year, over five years. It could well be that the business is stabilizing. While it is well worth considering the different impacts that market conditions can have on the share price, there are other factors that are even more important. For example, we've discovered 1 warning sign for Hainan Haiyao that you should be aware of before investing here.
海南海药在过去十二个月提供了3.6%的总回报率。 不幸的是,这低于市场回报。 但至少这依然是一个收益!在五年内,年度总回报率下降了5%。它可能确实表明业务正在稳定。 虽然考虑市场条件对股价的不同影响非常重要,但还有其他更重要的因素。例如,我们发现海南海药有一个警告信号,在投资之前你应该注意。
But note: Hainan Haiyao may not be the best stock to buy. So take a peek at this free list of interesting companies with past earnings growth (and further growth forecast).
但请注意:海南海药可能不是最好的买入股票。因此,请查看这份关于过去盈利增长(以及进一步增长预测)有趣公司的免费清单。
Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on Chinese exchanges.
请注意,本文中引用的市场回报反映了目前在中国交易所交易的股票的市场加权平均回报。
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
对本文有反馈?对内容有疑虑?请直接与我们联系。或者,发送电子邮件至 editorial-team (at) simplywallst.com。
这篇来自Simply Wall St的文章是一般性的。我们根据历史数据和分析师预测提供评论,采用无偏见的方法,我们的文章并不旨在提供财务建议。它不构成对任何股票的买入或卖出建议,也未考虑到您的目标或财务状况。我们旨在为您提供以基本数据驱动的长期分析。请注意,我们的分析可能未考虑最新的价格敏感公司公告或定性材料。Simply Wall St在提到的任何股票中均没有持仓。